Advertisement
Screener

PRECIGEN, INC. (PGEN) Auditor

PRECIGEN, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-25: Fiscal year end 2025-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Baltimore, Maryland.
  • 2025-03-19: Fiscal year end 2024-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Baltimore, Maryland.
  • 2024-04-29: Fiscal year end 2023-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 1288; Location Baltimore, MD..
  • 2024-03-19: Fiscal year end 2023-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Baltimore, Maryland.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-252025-12-31Deloitte & Touche LLP34Baltimore, MarylandNo
2025-03-192024-12-31Deloitte & Touche LLP34Baltimore, MarylandNo
2024-04-292023-12-31Deloitte & Touche LLP1288Baltimore, MD.No
2024-03-192023-12-31Deloitte & Touche LLP34Baltimore, MarylandNo
2023-03-062022-12-31Deloitte & Touche LLP34Baltimore, MarylandYes
2022-03-012021-12-31Deloitte & Touche LLP34Baltimore, MarylandYes
2021-03-012020-12-31Deloitte & Touche LLPBaltimore, MarylandYes
2020-03-022019-12-31Deloitte & Touche LLPBaltimore, Maryland
2019-03-012018-12-31PricewaterhouseCoopers LLPRaleigh, North Carolina
2018-03-012017-12-31PricewaterhouseCoopers LLPRaleigh, North Carolina
2017-03-012016-12-31PricewaterhouseCoopers LLPCharlotte, North Carolina
2016-02-292015-12-31PricewaterhouseCoopers LLPCharlotte, North Carolina
2015-03-022014-12-31PricewaterhouseCoopers LLPCharlotte, North Carolina
2014-03-312013-12-31PricewaterhouseCoopers LLPCharlotte, North Carolina

Similar stocks

Stock NameCountryMarket CapPE Ratio
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Immunome Inc. (IMNM)United States$2.538B-9.45
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67